
Dual-Action Approach Targeting Inflammation Shows Potential as Type 1 Diabetes Treatment | Newswise
Newswise — INDIANAPOLIS — A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of Type 1 diabetes by targeting an inflammation-related protein known to drive the disease. The findings, recently published in eBioMedicine, may help inform clinical trials of a drug that is…